HF
CELG

HRT Financial’s Celgene Corp CELG Stock Holding History

HRT Financial’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,436
Closed -$1.07M – 554
2018
Q2 		$1.07M Buy
+13,436
New +$1.12M 0.39% 39
2015
Q4 		– Sell
-3,822
Closed -$413K – 131
2015
Q3 		$413K Buy
+3,822
New +$474K 0.35% 42

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's CELG Position: Q3 2018 in Review

HRT Financial sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 13,436 shares — an estimated $1.07M sold.

HRT Financial first reported a position in CELG in Q3 2015 and held it in 2 quarters. The position peaked at $1.07M in Q2 2018. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • HRT Financial reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • HRT Financial sold 13,436 Celgene Corp shares in Q3 2018, an estimated $1.07M.
  • HRT Financial first reported a position in Celgene Corp in Q3 2015 and held it in 2 quarters.
  • HRT Financial's Celgene Corp position peaked at $1.07M in Q2 2018.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on HRT Financial's 13F filing for Q3 2018, filed 15 Nov 2018.